Evidence map›Paper›PMID 42183166›Full record

ReviewAmerican journal of nuclear medicine and molecular imaging2026

Shreyas Bulusu, Albab S Uddin, Oluwaseyi M Oderinde, Qi-Huang Zheng

Abstract readReview
In one paragraph

Review in American journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shreyas BulusuDepartment of Radiology and Imaging Sciences, Indiana University School of Medicine Indianapolis, IN, USA.
Albab S UddinDepartment of Radiology and Imaging Sciences, Indiana University School of Medicine Indianapolis, IN, USA.
Oluwaseyi M OderindeDepartment of Radiation Oncology, Indiana University School of Medicine Indianapolis, IN, USA.
Qi-Huang ZhengDepartment of Radiology and Imaging Sciences, Indiana University School of Medicine Indianapolis, IN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myocardial perfusion imaging (MPI) has served as a cornerstone of coronary artery disease (CAD) evaluation for over four decades, including many other cardiac diseases. MPI is extremely valuable for both diagnostic and prognostic purposes in clinical environments, enabling clinicians to evaluate a patient's coronary health. Perfusion scanning utilizes two primary imaging techniques: single-photon emission computed tomography (SPECT) and positron emission tomography (PET). Each relies on radioactive tracers, which are radioactive substances injected into a patient that spread across myocardial tissue and emit photons or positrons detectable by cameras. Traditional radiotracers include

Indexed as

18F-Flurpiridazcoronary artery disease (CAD)myocardial perfusion imaging (MPI)positron emission tomography (PET)radiotracersingle-photon emission computed tomography (SPECT)

Identifiers

PMID42183166
PMCPMC13191561

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.